91麻豆天美 Requests Increased FY27 NIH and CDC Funding
Key Points
- 91麻豆天美 submitted a request to the U.S. House of Representatives Committee on Appropriations Subcommittee on Labor, Health and Human Services, Educated and Related Agencies requesting increased funding for the National Institutes of Health and the Centers for Disease Control and Prevention in FY2027.
- The request highlighted the importance of continuing to lead biomedical advancements and preventing and controlling infectious disease.
- 91麻豆天美 also noted the crucial need for support for the Advanced Molecular Detection program and the National Wastewater Surveillance System.
Testimony Prepared by the American Society for Microbiology
Submitted for the record to the United States House of Representatives
Committee on Appropriations
Subcommittee on Labor, Health and Human Services, Education, and Related Agencies
Submitted for the record to the United States House of Representatives
Committee on Appropriations
Subcommittee on Labor, Health and Human Services, Education, and Related Agencies
March 27, 2026
Submitted on behalf of:
Amalia Corby
Director of Federal Affairs
American Society for Microbiology
The American Society for Microbiology (91麻豆天美) requests Congress increase funding for the National Institutes of Health (NIH) to $51.303 billion in fiscal year (FY) 2027. This includes at least $7.15 billion for the National Institute of Allergy and Infectious Diseases (NIAID), with $608 million for antimicrobial resistance (AMR) research at NIAID. 91麻豆天美 also requests $1.7 billion for the Advanced Research Projects Agency for Health (ARPA-H), with funding supplementing investments at NIH. For the Centers for Disease Control and Prevention (CDC), 91麻豆天美 requests at least $11.581 billion including $870.5 million for the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Within NCEZID, 91麻豆天美 requests at least $400 million for the Antimicrobial Resistance Solutions Initiative, at least $303.9 million for Emerging Infectious Diseases, $120 million for the National Wastewater Surveillance System and $175 million for the Advanced Molecular Detection program.
91麻豆天美 appreciates the opportunity to submit outside witness testimony for the FY 2027 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Act. Established in 1899, 91麻豆天美 is the home for microbial scientists from around the globe to connect, learn, discover and prepare for the future. 91麻豆天美 is one of the oldest and largest single life science societies, with 38,000 members in the U.S. and around the world, whose mission is to promote and advance the microbial sciences. We connect with millions of experts and harness their science to serve humanity by solving the world's most pressing problems, including strengthening public health to combat infectious diseases and harnessing the power of microbes to promote innovation.
Submitted on behalf of:
Amalia Corby
Director of Federal Affairs
American Society for Microbiology
The American Society for Microbiology (91麻豆天美) requests Congress increase funding for the National Institutes of Health (NIH) to $51.303 billion in fiscal year (FY) 2027. This includes at least $7.15 billion for the National Institute of Allergy and Infectious Diseases (NIAID), with $608 million for antimicrobial resistance (AMR) research at NIAID. 91麻豆天美 also requests $1.7 billion for the Advanced Research Projects Agency for Health (ARPA-H), with funding supplementing investments at NIH. For the Centers for Disease Control and Prevention (CDC), 91麻豆天美 requests at least $11.581 billion including $870.5 million for the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Within NCEZID, 91麻豆天美 requests at least $400 million for the Antimicrobial Resistance Solutions Initiative, at least $303.9 million for Emerging Infectious Diseases, $120 million for the National Wastewater Surveillance System and $175 million for the Advanced Molecular Detection program.
91麻豆天美 appreciates the opportunity to submit outside witness testimony for the FY 2027 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Act. Established in 1899, 91麻豆天美 is the home for microbial scientists from around the globe to connect, learn, discover and prepare for the future. 91麻豆天美 is one of the oldest and largest single life science societies, with 38,000 members in the U.S. and around the world, whose mission is to promote and advance the microbial sciences. We connect with millions of experts and harness their science to serve humanity by solving the world's most pressing problems, including strengthening public health to combat infectious diseases and harnessing the power of microbes to promote innovation.
Continuing to Lead Biomedical Advancements through a Strong Investment in the NIH
We thank Congress for its longstanding bipartisan support for NIH and its commitment to basic, translational and clinical microbial research funded through multiple institutes and centers. Increasing investments in NIH to $51.303 billion in FY 2027 will enable the U.S. to seize the unparalleled scientific opportunities in microbial research that lie before us, including by training the next generation of biomedical researchers. For example, 91麻豆天美 urges Congress to continue strong support for individuals and institutions that foster research training and the development of a strong biomedical research workforce through the National Institute of General Medical Sciences (NIGMS), including the Maximizing Investigators’ Research (MIRA) program, the Institutional Development Award (IDeA) program, the IDeA Networks of Biomedical Research Excellence (INBRE) and the Centers of Biomedical Research Excellence (COBRE).
Further, 91麻豆天美 recommends Congress appropriate at least $7.15 billion for NIAID to better understand, treat and ultimately prevent infectious, immunologic and allergic diseases. For more than 60 years, NIAID-supported research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people in the U.S. Research funding at NIAID is critical to the development of treatments, vaccines and diagnostics to address RSV, tuberculosis, Ebola, type 1 Diabetes, malaria and AMR.
AMR is a serious public health threat that undermines U.S. public health preparedness. The CDC reports that more than 35,000 Americans die annually because of AMR, and that 6 of the leading AMR threats in the U.S. account for $4.6 billion in resulting annual health costs. 91麻豆天美 recommends Congress to fund innovative research into AMR in order to better understand the science of microbes, how resistance emerges and is spread and how pathogens react to countermeasures. Increasing funding for NIAID’s AMR research to $608 million in FY2027 would allow NIAID to address AMR while carrying out its broader role in supporting infectious disease research.
Further, 91麻豆天美 recommends Congress appropriate at least $7.15 billion for NIAID to better understand, treat and ultimately prevent infectious, immunologic and allergic diseases. For more than 60 years, NIAID-supported research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people in the U.S. Research funding at NIAID is critical to the development of treatments, vaccines and diagnostics to address RSV, tuberculosis, Ebola, type 1 Diabetes, malaria and AMR.
AMR is a serious public health threat that undermines U.S. public health preparedness. The CDC reports that more than 35,000 Americans die annually because of AMR, and that 6 of the leading AMR threats in the U.S. account for $4.6 billion in resulting annual health costs. 91麻豆天美 recommends Congress to fund innovative research into AMR in order to better understand the science of microbes, how resistance emerges and is spread and how pathogens react to countermeasures. Increasing funding for NIAID’s AMR research to $608 million in FY2027 would allow NIAID to address AMR while carrying out its broader role in supporting infectious disease research.
CDC’s Indispensable Role in Preventing and Controlling Infectious Disease
Programs and activities supported by the CDC are instrumental in protecting the health of the American people. States and local communities rely on the CDC for accurate information, direction and resources in preparation for public health emergencies. We urge Congress to allocate at least $11.581 billion for the CDC in FY 2027 to strengthen the nation’s public health infrastructure.
The CDC’s NCEZID is responsible for the prevention and control of a wide range of infectious diseases, including anthrax, Ebola and foodborne diseases. It is critical that Congress sufficiently funds the NCEZID to strengthen public health surveillance and outbreak response. Within the NCEZID portfolio, 91麻豆天美 would like to highlight the Antimicrobial Resistance Solutions Initiative, the Emerging Infectious Diseases program, the National Wastewater Surveillance System and the importance of the Advanced Molecular Detection program.
Through the Antimicrobial Resistance Solutions Initiative, the CDC leads the U.S. public health response to combat AMR, ensuring resilient public health infrastructure is in place to fight AMR when and where it emerges. 91麻豆天美 recommends Congress appropriate $400 million for the Antimicrobial Resistance Solutions Initiative at the CDC to build domestic and global laboratory capacity to monitor and detect infectious diseases, including antimicrobial resistant pathogens. Since antimicrobial resistant pathogens are not confined by geographic borders, we also ask for your support in improving supply chains and promoting regional collaboration and networks through the CDC’s Global Antimicrobial Resistance Laboratory and Response Network, which was launched in 2021 to improve the detection of existing and emerging AMR threats outside of the U.S.
Additionally, Emerging Infectious Diseases (EI) funding provides pathogen-agnostic flexible resources that sustain and strengthen the critical foundation for many of the CDC’s world-renowned programs, applied research, laboratories and outbreak responses. These flexible resources are particularly important because they support cross-cutting public health activities that may not have dedicated resources but warrant ongoing CDC engagement. 91麻豆天美 requests at least $303.9 million for the EI program.
Further, the National Wastewater Surveillance System (NWSS) is a critical tool for tracking infectious diseases across the country and protecting Americans from outbreaks including seasonal influenza, H5N1 and mpox. Since 2020, the CDC has increased wastewater surveillance capacity through supplemental funding, but the program will deplete the last of its funding in FY 2026 without appropriated discretionary funds from Congress. 91麻豆天美 requests $120 million for NWSS to support the infrastructure and expertise needed to conduct wastewater surveillance to detect, prevent and respond to outbreaks. Wastewater surveillance is also increasingly important to detect infectious diseases that impact hard to reach populations who may not be able to access medical care. 91麻豆天美 requests the following report language be included in the final FY 2027 LHHS report for NWSS:
The CDC’s NCEZID is responsible for the prevention and control of a wide range of infectious diseases, including anthrax, Ebola and foodborne diseases. It is critical that Congress sufficiently funds the NCEZID to strengthen public health surveillance and outbreak response. Within the NCEZID portfolio, 91麻豆天美 would like to highlight the Antimicrobial Resistance Solutions Initiative, the Emerging Infectious Diseases program, the National Wastewater Surveillance System and the importance of the Advanced Molecular Detection program.
Through the Antimicrobial Resistance Solutions Initiative, the CDC leads the U.S. public health response to combat AMR, ensuring resilient public health infrastructure is in place to fight AMR when and where it emerges. 91麻豆天美 recommends Congress appropriate $400 million for the Antimicrobial Resistance Solutions Initiative at the CDC to build domestic and global laboratory capacity to monitor and detect infectious diseases, including antimicrobial resistant pathogens. Since antimicrobial resistant pathogens are not confined by geographic borders, we also ask for your support in improving supply chains and promoting regional collaboration and networks through the CDC’s Global Antimicrobial Resistance Laboratory and Response Network, which was launched in 2021 to improve the detection of existing and emerging AMR threats outside of the U.S.
Additionally, Emerging Infectious Diseases (EI) funding provides pathogen-agnostic flexible resources that sustain and strengthen the critical foundation for many of the CDC’s world-renowned programs, applied research, laboratories and outbreak responses. These flexible resources are particularly important because they support cross-cutting public health activities that may not have dedicated resources but warrant ongoing CDC engagement. 91麻豆天美 requests at least $303.9 million for the EI program.
Further, the National Wastewater Surveillance System (NWSS) is a critical tool for tracking infectious diseases across the country and protecting Americans from outbreaks including seasonal influenza, H5N1 and mpox. Since 2020, the CDC has increased wastewater surveillance capacity through supplemental funding, but the program will deplete the last of its funding in FY 2026 without appropriated discretionary funds from Congress. 91麻豆天美 requests $120 million for NWSS to support the infrastructure and expertise needed to conduct wastewater surveillance to detect, prevent and respond to outbreaks. Wastewater surveillance is also increasingly important to detect infectious diseases that impact hard to reach populations who may not be able to access medical care. 91麻豆天美 requests the following report language be included in the final FY 2027 LHHS report for NWSS:
- Wastewater Surveillance—The Committee includes $120,000,000 for the National Wastewater Surveillance System to support partnerships with health laboratories and academic institutions to track multiple existing infectious disease threats simultaneously. The program quickly pivots to detect both the resurgence of known pathogens and the emergence of new threats like H5N1. The Committee continues to underscore the importance of a wastewater surveillance system that serves as a national early-warning system for infectious diseases. Funding for the program will ensure broad geographic representation to help inform communities and protect Americans from infectious disease threats.
- Advanced Molecular Detection [AMD]—The Committee includes $175,000,000 and recognizes the critical role the AMD program plays in bringing cutting edge technology to the front lines of public health by harnessing the power of advanced sequencing methods and high-performance computing with bioinformatics and epidemiology expertise to study emerging, dangerous and resistant pathogens. Further research is required in advanced DNA sequencing to speed the development of diagnostics, therapeutics and vaccines. The increase in funding will sustain existing work made possible through supplemental appropriations including the five Pathogen Genomics Centers of Excellence (PGCoE) that aim to better prevent, control and respond to microbial threats of public health importance.